4MF0
ITK kinase domain in complex with benzothiazole inhibitor compound 12a (1S,2S)-2-{4-[(DIMETHYLAMINO)METHYL]PHENYL}-N-[6-(PYRIDIN-3-YL)-1,3-BENZOTHIAZOL-2-YL]CYCLOPROPANECARBOXAMIDE (12a)
Entity
Entity ID | Chain ID | Description | Type | Chain length | Formula weight | Number of molecules | DB Name (Accession) | Biological source | Descriptive keywords |
1 | A, B | Tyrosine-protein kinase ITK/TSK | polymer | 266 | 30214.5 | 2 | UniProt (Q08881) Pfam (PF07714) In PDB | Homo sapiens (human) | Interleukin-2-inducible T-cell kinase, IL-2-inducible T-cell kinase, Kinase EMT, T-cell-specific kinase, Tyrosine-protein kinase Lyk |
2 | A, B | (1S,2S)-2-{4-[(dimethylamino)methyl]phenyl}-N-[6-(pyridin-3-yl)-1,3-benzothiazol-2-yl]cyclopropanecarboxamide | non-polymer | 428.5 | 2 | Chemie (29Z) | |||
3 | water | water | 18.0 | 25 | Chemie (HOH) |
Sequence modifications
A, B: 357 - 620 (UniProt: Q08881)
PDB | External Database | Details |
---|---|---|
Gly 355 | - | expression tag |
Ser 356 | - | expression tag |
Glu 512 | Tyr 512 | engineered mutation |
Sequence viewer
Contents of the asymmetric unit
Polymers | Number of chains | 2 |
Total formula weight | 60429.0 | |
Non-Polymers* | Number of molecules | 2 |
Total formula weight | 857.1 | |
All* | Total formula weight | 61286.1 |